-
Nepali rescuers buoyed by miracle finds but tough conditions persist
-
Indonesia's main airport suspends operations after volcanic eruption
-
At last: Straight sets win over Tabilo puts Zverev in US Open last 16
-
US aircraft carrier departs Thailand after port call
-
Jovic 'loses sanity five times over' to oust friend Eala in US Open epic
-
Haze emergency grips Malaysian Borneo town
-
China's memories of Mao fade to nostalgia 50 years after his death
-
Messi creates both Miami goals in 2-2 draw with Atlanta
-
US envoys discuss with Putin 'substantive' plans for steps to end Ukraine war
-
Rybakina books US Open fourth-round berth, inches closer to No. 1
-
Zheng stuns Keys as US Open upsets dim American hopes
-
Sobering reality: Curbs on alcohol in northeast Syria cause discontent
-
Jovic 'loses sanity five times over' to oust Eala and book Gauff clash
-
Wobbly Osaka 'shocked' to battle past Mertens and reach last 16
-
'Like a jewel': Japan's luxury ice revered by bars worldwide
-
Indian Oscar-nominated filmmaker turns camera on his cancer
-
'The flood is coming': How a Nepal principal saved 900 students
-
Argentina 'let off hook' by Australia as Kiss's winning run ends
-
Kiss's winning run ends as Argentina hold Australia to draw
-
Argentina threatens to sanction oil projects around Falklands
-
Alcaraz excited to face 'dangerous' Paul for US Open quarter-final berth
-
Gauff into round four at US Open after straight-set win
-
Prince William to represent King Charles III at Norway late King Harald's funeral
-
Bordeaux hammer Racing in Top 14 start as Bielle-Biarrey extends deal
-
Inter and Roma roar back to win thrillers and share top spot
-
Zheng, Potapova pull off upsets to reach US Open last 16
-
Don't stop them now: fans party for Freddie Mercury's 80th birthday
-
Swiatek into US Open fourth round in tight two-setter
-
AFP photographer wins top prize for Madagascar protest coverage
-
Werro wins in Brussels, as Russell and Dos Santos shine
-
Keys: 'I felt like I couldn't play tennis'
-
Kolbe breaks jaw and shoulder injury sidelines Savea
-
Simmonds stars as Pau upset Montpellier
-
US military strikes oil tankers as Iran vows tougher reprisals
-
Inter roar back in five-goal thriller with Napoli
-
Zheng rallies to stun Keys, Anisimova out in US Open third round
-
Haaland keeps Man City perfect in Premier League, blunt Spurs held
-
Bayern held to draw by stubborn Schalke
-
Hamilton worried by Ferrari pace while Antonelli prepares for a fight
-
Lens lose again ahead of Champions League date
-
Vuelta stage 15 shortened due to extreme heat, Mas consolidates lead
-
Olympic champion Zheng storms home to reach US Open last 16
-
Putin meets US envoys for Ukraine war talks
-
Big-spending Spurs must make better attacking decisions, says De Zerbi
-
Modric available for Croatia in Nations League
-
South Africa dominate New Zealand in second half to lead series
-
Potapova upsets 2025 US Open runner-up Anisimova
-
Kiefer Sutherland still in action, but ibuprofen lending helping hand
-
Gasly a 'class act' says Alpine boss after Monza pole
-
'Are we ready?' Oasis film captures band's frosty reunion
MD+DI Names Babson Diagnostics, 2024 Medtech Company of the Year
MD+DI editors mark Babson Diagnostics as a notable true solution to deliver simplified blood testing through BetterWay.
Medical Device & Diagnostic Industry (MD+DI), the leading business-to-business media brand covering the medtech industry, has named Babson Diagnostics its 2024 Medtech Company of the Year.
For more than a decade, MD+DI's editors have recognized the Medtech Company of the Year annually to highlight medical device or diagnostic industry players that have risen above the competition with standout technologies, exceptional business results or other achievements. Past winners have included Abbott Laboratories, Boston Scientific and Hologic.
The Medtech Company of the Year selected for 2024 is Babson Diagnostics, in recognition of its BetterWay blood tests, which uses a pea-sized sample of blood collected from a fingertip without the need for a phlebotomist. BetterWay testing launched this year at select locations in Austin, TX, and starts at just $15.
"Babson Diagnostics has tremendously overcome much industry skepticism, due to challenges infamously from other organizations in the past claiming to offer similar premises but never fulfilling the expectations of a seamless, blood testing experience for patients," says Omar Ford, Editor-in-Chief, MD+DI. "BetterWay is a brilliantly simple solution that delivers what was once the dream, to genuinely increase accessibility to patient care, efficiency and personalization, all while being up to half the cost of other self-pay blood tests."
In addition to launching BetterWay tests this past summer, Babson Diagnostics also announced a strategic investment from BD in October. Other milestones for the company this year included validation of its proprietary hand-warming device, which supports improved collection of capillary blood samples, as well as the establishment of a dedicated clinician relations team.
"Almost every conversation we have, some doubt comes into the picture," shares Eric Olson, founder and COO of Babson Diagnostics. "When somebody is trying to understand what we are doing, they always want to know how this compares to other technologies. We realized early on that the way that you deal with that is through science and transparency. It is not enough to just say that we are different than what has happened in the past, in this industry you have to prove it, and we have done just that."
Babson Diagnostics was also selected as The Readers' Choice Medtech Company of the Year, through MD+DI's audience's online vote.
The nine other finalists for the 2024 Medtech Company of the Year were: Abbott Laboratories, Boston Scientific, Edwards Lifesciences, Fractyl, Intuitive Surgical, Medtronic, Senseonics, Solventum and Stryker.
Stay up to date with the latest trends and topics for medical devices and in vitro diagnostic products at: mddionline.com/
About MD+DI
Medical Device and Diagnostic Industry (MD+DI) is the primary resource for manufacturers of medical devices and in vitro diagnostic products. Its mission is to help medtech industry professionals develop, design, and manufacture products that comply with complex and demanding regulations and evolving market requirements. For more than 40 years, MD+DI's editorial quality and reliability have won it an unparalleled degree of trust from the industry. Some of the best and brightest experts in medtech contribute to MD+DI, and many of their articles have become standards of reference for the medical device industry.
Through its associated Qmed+ directory, MD+DI connects readers with qualified suppliers offering the latest products, services and equipment for the medtech industry. As a prominent part of the global Informa Markets - Engineering portfolio, MD+DI is also the official media partner of the MD&M West, MD&M Minneapolis, MD&M East, MD&M South, MEDevice Boston, and MEDevice Silicon Valley events.
Our broader network of related events and media brands serves high-growth industries across the advanced manufacturing sector.
About Informa Markets Engineering
Informa Markets Engineering is the leading B2B event producer, publisher, and digital media business for the world's $3-trillion advanced, technology-based manufacturing industry. Our print and electronic products deliver trusted information to the engineering market and leverage our proprietary 1.3-million-name database to connect suppliers with buyers and purchase influencers. We produce more than 50 events and conferences in a dozen countries, connecting manufacturing professionals from around the globe. The Engineering portfolio is organized by Informa Markets, a subsidiary of Informa plc (LON:INF), the world's leading exhibitions organizer that brings a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com.
Media Contact
Informa Markets Engineering PR
[email protected]
SOURCE: INFORMA MARKETS - ENGINEERING
A.Ruiz--AT